We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
+19.17%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$194M
AUM Growth
-$9.63M
(-4.7%)
Cap. Flow
-$23M
Cap. Flow
% of AUM
-11.82%
Top 10 Holdings %
Top 10 Hldgs %
42.43%
Holding
82
New
25
Increased
12
Reduced
19
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.4M |
| 2 |
McDonald's
MCD
|
+$7.39M |
| 3 |
Ulta Beauty
ULTA
|
+$5.53M |
| 4 |
Royal Caribbean
RCL
|
+$5.33M |
| 5 |
Netflix
NFLX
|
+$5.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ADPT
Adeptus Health Inc
ADPT
|
+$10.7M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$8.41M |
| 3 |
Advance Auto Parts
AAP
|
+$6.08M |
| 4 |
Martin Marietta Materials
MLM
|
+$4.91M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$4.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.69% |
| 2 | Consumer Discretionary | 21.53% |
| 3 | Communication Services | 17.74% |
| 4 | Technology | 8.56% |
| 5 | Materials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Neurocrine Biosciences
NBIX
$16.8B
| $2.83M | 1.46% |
50,000
-23,500
| -32% | -$1.19M |
|
|
LKFT
27
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
| $2.64M | 1.36% |
42,000
-23,500
| -36% | -$1.2M |
|
|
GRA
28
DELISTED
W.R. Grace & Co.
GRA
| $2.64M | 1.36% |
+26,500
| New | +$2.59M |
|
29
Trip.com Group
TCOM
$29.6B
| $2.62M | 1.35% |
+56,500
| New | +$2.58M |
|
30
Gentherm
THRM
$1.25B
| $2.61M | 1.34% |
55,000
+12,000
| +28% | +$575K |
|
|
SUM
31
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $2.57M | 1.32% |
134,077
-35,406
| -21% | -$722K |
|
32
Ionis Pharmaceuticals
IONS
$8.6B
| $2.35M | 1.21% |
+38,000
| New | +$2.05M |
|
33
Eli Lilly
LLY
$1.02T
| $2.27M | 1.17% |
27,000
+19,500
| +260% | +$1.62M |
|
34
TransDigm Group
TDG
$70.2B
| $2.08M | 1.07% |
9,100
-1,900
| -17% | -$428K |
|
35
Vail Resorts
MTN
$5.32B
| $2.04M | 1.05% |
+15,900
| New | +$1.87M |
|
36
Amazon
AMZN
$2.92T
| $2.03M | 1.04% |
+60,000
| New | +$1.89M |
|
37
Alkermes
ALKS
$8.22B
| $2.02M | 1.04% |
+25,500
| New | +$1.79M |
|
|
SIOX
38
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.89M | 0.97% |
13,125
+3,750
| +40% | +$488K |
|
|
AET
39
DELISTED
Aetna Inc
AET
| $1.84M | 0.95% |
+17,000
| New | +$1.84M |
|
40
Williams Companies
WMB
$87.5B
| $1.81M | 0.93% |
+70,500
| New | +$2.46M |
|
41
Zoetis
ZTS
$32.4B
| $1.75M | 0.9% |
+36,500
| New | +$1.65M |
|
|
ABMD
42
DELISTED
Abiomed Inc
ABMD
| $1.72M | 0.88% |
19,000
-56,000
| -75% | -$4.75M |
|
43
Barrett Business Services
BBSI
$959M
| $1.35M | 0.69% |
124,000
+36,000
| +41% | +$397K |
|
|
RDUS
44
DELISTED
Radius Health, Inc.
RDUS
| $1.26M | 0.65% |
20,500
-22,500
| -52% | -$1.42M |
|
|
45
Advance Auto Parts
AAP
$3.35B
| $1.2M | 0.62% |
8,000
-35,000
| -81% | -$6.08M |
|
46
Prothena Corp
PRTA
$425M
| $1.02M | 0.53% |
+15,000
| New | +$905K |
|
|
FRAN
47
DELISTED
Francesca's Holdings Corporation
FRAN
| $1M | 0.52% |
+4,792
| New | +$840K |
|
|
INSY
48
PUT
DELISTED
Insys Therapeutics, Inc.
INSY
| $956K | 0.49% |
+33,400
| New | +$925K |
|
|
KITE
49
CALL
DELISTED
Kite Pharma, Inc.
KITE
| $771K | 0.4% |
12,500
-14,700
| -54% | -$1.03M |
|
|
VTAE
50
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $724K | 0.37% |
40,000
-5,000
| -11% | -$68.8K |
|
Similar funds
AGA
RIM
ACM
CAM
LSA
GWA
HP
Atika Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, Atika Capital Management held 82 positions worth $194M, down 4.7% from $204M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Atika Capital Management withdrew a net $23M in Q4 2015, closing 26 positions and reducing 19 holdings. Its most notable exit was Adeptus Health Inc, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Atika Capital Management opened a new position in Microsoft worth $13.1M.
- Atika Capital Management's largest Q4 2015 buy was Microsoft: 236,000 shares worth $13.1M.
- Atika Capital Management added most to Netflix in Q4 2015, an estimated $5.26M increase.
- Atika Capital Management's biggest Q4 2015 reduction was Advance Auto Parts, cutting an estimated $6.08M.
- Atika Capital Management fully exited Adeptus Health Inc in Q4 2015, selling an estimated $10.7M.
- Atika Capital Management's ten largest holdings make up 42% of its $194M portfolio in Q4 2015.
- Atika Capital Management opened 25 new positions and closed 26 in Q4 2015.
- Atika Capital Management's portfolio value fell 4.7% quarter-over-quarter to $194M.
Based on Atika Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.